Kimberly Chong

Array ( [id] => 10013133 [patent_doc_number] => 09056135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'MicroRNA biomarkers for human breast and lung cancer' [patent_app_type] => utility [patent_app_number] => 13/478408 [patent_app_country] => US [patent_app_date] => 2012-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37471 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465755 [patent_doc_number] => 20120270924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'Oligomeric Compounds For The Modultion of HIF-1A Expression' [patent_app_type] => utility [patent_app_number] => 13/477825 [patent_app_country] => US [patent_app_date] => 2012-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16418 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13477825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166468 [patent_doc_number] => 08592145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent' [patent_app_type] => utility [patent_app_number] => 13/472190 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12259 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166468 [patent_doc_number] => 08592145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent' [patent_app_type] => utility [patent_app_number] => 13/472190 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12259 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166468 [patent_doc_number] => 08592145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent' [patent_app_type] => utility [patent_app_number] => 13/472190 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12259 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166468 [patent_doc_number] => 08592145 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Cancer marker, method for evaluation of cancer by using the cancer marker, and evaluation reagent' [patent_app_type] => utility [patent_app_number] => 13/472190 [patent_app_country] => US [patent_app_date] => 2012-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 12259 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13472190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509106 [patent_doc_number] => 20120308515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'USE OF GILZ PROTEIN EXPRESSED IN DENDRITIC CELLS TO MODULATE AN ANTIGEN-SPECIFIC IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 13/468112 [patent_app_country] => US [patent_app_date] => 2012-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8931 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10542020 [patent_doc_number] => 09267134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-23 [patent_title] => 'Methods of modulating MicroRNAs in the treatment of pulmonary arterial hypertension' [patent_app_type] => utility [patent_app_number] => 14/116724 [patent_app_country] => US [patent_app_date] => 2012-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 19 [patent_no_of_words] => 18298 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9569891 [patent_doc_number] => 20140187604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'THERAPEUTIC AND DIAGNOSTIC TARGET GENE IN ACUTE MYELOID LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 14/113405 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 17764 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8649636 [patent_doc_number] => 20130035367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDES THAT TARGET A CRYPTIC SPLICE SITE IN USH1C AS A THERAPEUTIC FOR USHER SYNDROME' [patent_app_type] => utility [patent_app_number] => 13/461565 [patent_app_country] => US [patent_app_date] => 2012-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7939 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13461565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10580939 [patent_doc_number] => 09303057 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Methods and reagents for analyzing riboswitches using FRET' [patent_app_type] => utility [patent_app_number] => 13/459989 [patent_app_country] => US [patent_app_date] => 2012-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11052 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13459989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8442385 [patent_doc_number] => 20120259001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation' [patent_app_type] => utility [patent_app_number] => 13/460026 [patent_app_country] => US [patent_app_date] => 2012-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15815 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13460026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10161412 [patent_doc_number] => 09192622 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'MicroRNA-130a,b as a tumor suppressor and sensitizing agent for chemotherapy' [patent_app_type] => utility [patent_app_number] => 13/437251 [patent_app_country] => US [patent_app_date] => 2012-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 8035 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13437251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10635876 [patent_doc_number] => 09353370 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Functional nucleic acid molecule and use thereof' [patent_app_type] => utility [patent_app_number] => 14/008186 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16030 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586971 [patent_doc_number] => 20130005791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/434820 [patent_app_country] => US [patent_app_date] => 2012-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17481 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13434820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371258 [patent_doc_number] => 20120220645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'GENETIC CHANGES IN ATM AND ATR/CHEK1 AS PROGNOSTIC INDICATORS IN CANCER' [patent_app_type] => utility [patent_app_number] => 13/407165 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 32180 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13407165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359703 [patent_doc_number] => 20120214865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'METHODS FOR SLOWING FAMILIAL ALS DISEASE PROGRESSION' [patent_app_type] => utility [patent_app_number] => 13/406256 [patent_app_country] => US [patent_app_date] => 2012-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9689 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13406256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11263490 [patent_doc_number] => 09487777 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-08 [patent_title] => 'RNAi probes targeting cancer-related proteins' [patent_app_type] => utility [patent_app_number] => 13/404741 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 7675 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13404741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8323886 [patent_doc_number] => 20120196298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-02 [patent_title] => 'MITOCHONDRIAL FUNCTION OF PROHIBITIN 2 (PHB2)' [patent_app_type] => utility [patent_app_number] => 13/402933 [patent_app_country] => US [patent_app_date] => 2012-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10439 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335507 [patent_doc_number] => 20120202215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'MITOCHONDRIAL FUNCTION OF PROHIBITIN 2 (PHB2)' [patent_app_type] => utility [patent_app_number] => 13/402955 [patent_app_country] => US [patent_app_date] => 2012-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 10440 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13402955 [rel_patent_id] =>[rel_patent_doc_number] =>)